Genetic variants that lower the threshold for immune activation during breast cancer may be more common in Asian populations—for example, germline deletion of the APOBEC3B gene, a cytidine deaminase that has roles in both cancer mutagenesis and innate immunity, is much more common in Asian and Oceanic populations than in Western populations [45, 46]. This evidence concerns the gene APOBEC3B and breast cancer.